openPR Logo
Press release

Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Diseases Raise Thyroid Disorder Fears Globally

03-13-2018 02:05 PM CET | Health & Medicine

Press release from: Transparency Market Research

Thyroid Gland Disorder Treatment Market: Increasing incidence

The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of thyroid gland disorder patients across the globe, preference to alternative treatment methods brings down the growth prospects of companies operating in the market. Nevertheless, with innovative marketing strategies and attempts at improving awareness among patients regarding the benefits of popular drugs could help companies strengthen their positions in the global thyroid gland disorders treatment market.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3113

Some of the leading companies in the market are Merck KGaA, Takeda Pharmaceutical Company Limited, Pfizer, Inc., ALLERGAN, Novartis AG, AbbVie Inc., Sanofi S.A., Lannett Company, Inc., Aspen, and Mylan N.V.

The global thyroid gland disorders treatment market had a valuation of US$1,954.7 mn in 2016 and is estimated to rise to a valuation of US$2,609.9 mn by 2025, expanding at a CAGR of 3.3% from 2017 to 2025.

On the basis of disorders, the global thyroid gland disorders treatment market has been categorized into hypothyroidism and hyperthyroidism. The hypothyroidism segment studies Levothyroxine and Liothyronine drug classes. Of these, the segment of Levothyroxine drug class accounted for nearly 94.6% share of the hypothyroidism treatment market in 2016 and is likely to remain dominant during the forecast period.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3113

Geographically, the market in North America is presently the dominant regional market for thyroid gland disorders treatment. The rising incidence rate of thyroid disorders in the region is the biggest factor emphasizing the need for effective treatments. The American Thyroid Association states that nearly 20,000,000 Americans are suffering from thyroid disorders and nearly 60% of this figure are unaware of the condition due to the non-specific nature of symptoms.

The global market for thyroid gland disorder treatment is likely to witness a steady rise in patient population across developed as well as developing economies. Factors such as sedentary lifestyle, rising pool of geriatrics, which is a demographic more susceptible to thyroid gland disorders, and an increased rate of prevalence of autoimmune diseases such as Grave’s disease and Hashimoto's thyroiditis are primarily contributing to the increased patient population for thyroid gland disorders. The rising patient pool and the unresolved issue of iodine deficiency in diets of people across several emerging economies can also be considered some of the leading factors spelling growth for the market.

Factors such as the introduction of innovative therapeutic options from leading pharmaceutical companies, increasing awareness among people about the available treatments, and rising disposable incomes and affordability of generic or branded pharmaceutical formulations in emerging economies are also driving the market. However, the easy availability of generic drugs and high preference of patients to alternative therapies such as thyroid surgery and herbal medicines could hamper the growth prospects of the market to a certain extent.

Report Overview @ https://www.transparencymarketresearch.com/thyroid-gland-disorder-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Diseases Raise Thyroid Disorder Fears Globally here

News-ID: 976829 • Views:

More Releases from Transparency Market Research

Cleanroom Consumables Market Forecast 2034: Growth Fueled by Stringent Contamination Control Standards in Pharma and Semiconductor Industries | Transparency Market Research, Inc
Cleanroom Consumables Market Forecast 2034: Growth Fueled by Stringent Contamina …
The global cleanroom consumables market is poised for remarkable expansion, with projections estimating its value will more than double from US$ 9,880.6 million in 2023 to over US$ 20,251.5 million by 2034. According to recent market intelligence, the industry is set to grow at a robust CAGR of 6.8% during the forecast period (2024-2034), underpinned by rising demands for contamination-free environments across pharmaceuticals, biotechnology, semiconductors, and medical device manufacturing. Market Overview:
Peptide API Market Forecast 2034: Expansion of Biopharmaceutical R&D and Demand for Targeted Therapies Propel Market Growth | Transparency Market Research, Inc
Peptide API Market Forecast 2034: Expansion of Biopharmaceutical R&D and Demand …
The global Peptide Active Pharmaceutical Ingredients (API) market is poised for explosive growth, with its valuation expected to surge from US$ 9.2 Bn in 2023 to over US$ 94.2 Bn by 2034, expanding at a CAGR of 22.4% during the forecast period. This expansion is propelled by the increasing global burden of chronic diseases, particularly diabetes and obesity, coupled with the rising adoption of GLP-1 receptor agonists and insulin-based peptide
Global In-vitro Inflammatory Bowel Disease Diagnostics Market Forecast 2034: Rising IBD Incidence and Advancements in Non-invasive Testing Drive Market Growth | Transparency Market Research, Inc
Global In-vitro Inflammatory Bowel Disease Diagnostics Market Forecast 2034: Ris …
The global In-vitro Inflammatory Bowel Disease (IBD) Diagnostics Market is poised for substantial growth over the next decade, projected to expand from US$ 1.6 Bn in 2023 to over US$ 2.9 Bn by 2034, at a steady CAGR of 5.6% during the forecast period 2024-2034. This growth is primarily driven by rising global incidence of Crohn's disease and ulcerative colitis, improved diagnostic technologies, and the increasing demand for personalized and
U.S. Liposomal Vitamins and Minerals Market Forecast 2034: Demand for Enhanced Nutrient Delivery Systems and Preventive Healthcare Drives Market Growth | Transparency Market Research, Inc
U.S. Liposomal Vitamins and Minerals Market Forecast 2034: Demand for Enhanced N …
The U.S. liposomal vitamins and minerals market is witnessing a significant surge as consumers increasingly prioritize health, wellness, and advanced nutritional supplementation. Valued at US$ 122.9 Mn in 2023, the market is projected to grow at a robust CAGR of 7.6% and exceed US$ 271.8 Mn by 2034, according to recent industry analysis. This growth is driven by factors such as the aging population, heightened health awareness, technological innovations in

All 5 Releases


More Releases for Thyroid

Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
The Thyroid Function Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Thyroid Function Test Market Size During the Forecast Period? The thyroid function test market has grown significantly in recent years. It is expected to grow from $1.7 billion in 2024
Empowering Individuals with Convenient, Accurate Thyroid Monitoring: The Rising …
In an era where digital health innovations are reshaping patient care, thyroid home test kits have emerged as a transformative solution for millions worldwide. As thyroid disorders continue to affect an estimated 200 million people globally, the demand for at-home diagnostic tools has skyrocketed. Offering rapid results, ease of use, and the power to take charge of one's health from the comfort of home, these kits are paving the way
Injectable Thyroid Drug Market: A Comprehensive Overview
​​In 2023, the global injectable thyroid drug market was valued at approximately USD 414.4 million. Projections indicate that by 2032, the market will reach around USD 671.12 million, reflecting a compound annual growth rate (CAGR) of about 5.6% from 2024 to 2032. Injectable Thyroid Drug Market Overview Injectable thyroid drugs are primarily used to manage thyroid disorders such as hypothyroidism, hyperthyroidism, and thyroid cancer. The market's growth is driven by the increasing
[Latest] Thyroid Disorder Treatment Market : An Overview
The ""Thyroid Disorder Treatment Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Thyroid Disorder Treatment Market, 2024-2031 Verified Market Research's most recent report, ""Thyroid Disorder Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,""
Thyroid Function Test Market Report 2024 - Thyroid Function Test Market Growth A …
"The Business Research Company recently released a comprehensive report on the Global Thyroid Function Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Thyroid Function Test Market Size, Future Trends
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: Thyroid Function Test Market was valued at USD 1.30 Billion in 2018 and is projected to reach USD 2.06 Billion by 2026, growing at a CAGR of 5.89 % from 2019 to 2026. Market Overview for Thyroid Function Test Market Thyroid Function Test Market OverviewThe thyroid function test market is experiencing robust growth driven by increasing incidences of thyroid disorders worldwide. These tests play a crucial role in diagnosing